ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 278 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2022. The put-call ratio across all filers is 0.90 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $178,470 | -43.3% | 6,642 | -24.7% | 0.01% | -40.0% |
| Q2 2023 | $314,735 | +190648.5% | 8,826 | +35.7% | 0.01% | +100.0% |
| Q1 2023 | $165 | -16.2% | 6,506 | +33.6% | 0.01% | -37.5% |
| Q4 2022 | $197 | -100.0% | 4,868 | -68.2% | 0.01% | 0.0% |
| Q3 2022 | $505,000 | +77.2% | 15,294 | +88.6% | 0.01% | +33.3% |
| Q2 2022 | $285,000 | +119.2% | 8,109 | +185.8% | 0.01% | +500.0% |
| Q1 2022 | $130,000 | -76.7% | 2,837 | -66.4% | 0.00% | -90.0% |
| Q4 2021 | $559,000 | -34.5% | 8,433 | -38.3% | 0.01% | -54.5% |
| Q3 2021 | $854,000 | +20.5% | 13,674 | +59.6% | 0.02% | +22.2% |
| Q2 2021 | $709,000 | -30.5% | 8,568 | -44.3% | 0.02% | +5.9% |
| Q1 2021 | $1,020,000 | +93.5% | 15,374 | +123.8% | 0.02% | +6.2% |
| Q4 2020 | $527,000 | +146.3% | 6,869 | +37.8% | 0.02% | +700.0% |
| Q3 2020 | $214,000 | -80.5% | 4,983 | -80.4% | 0.00% | -95.6% |
| Q2 2020 | $1,099,000 | +272.5% | 25,457 | +446.9% | 0.04% | +80.0% |
| Q4 2019 | $295,000 | +23.9% | 4,655 | -44.9% | 0.02% | +56.2% |
| Q3 2019 | $238,000 | +2063.6% | 8,453 | +2008.0% | 0.02% | +1500.0% |
| Q2 2019 | $11,000 | +450.0% | 401 | +301.0% | 0.00% | – |
| Q1 2019 | $2,000 | -90.0% | 100 | -93.6% | 0.00% | -100.0% |
| Q4 2018 | $20,000 | 0.0% | 1,573 | +51.2% | 0.00% | 0.0% |
| Q3 2018 | $20,000 | -78.0% | 1,040 | -95.8% | 0.00% | -91.7% |
| Q4 2017 | $91,000 | – | 24,715 | – | 0.01% | – |
| Q3 2017 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
| Q2 2017 | $89,000 | +790.0% | 54,803 | +755.4% | 0.01% | +900.0% |
| Q4 2016 | $10,000 | – | 6,407 | +106683.3% | 0.00% | – |
| Q3 2016 | $0 | -100.0% | 6 | -99.5% | 0.00% | -100.0% |
| Q2 2016 | $7,000 | – | 1,274 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |